Bank Of America Corp Cytokinetics Inc Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of America Corp holds 4,777,628 shares of CYTK stock, worth $253 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,777,628

Previous 266,771 1690.91%

Holding current value

$253 Million

Previous $22.3 Million 1403.95%

% of portfolio

0.03%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $288 Million - $487 Million	4,510,857 Added 1690.91%	4,777,628 $335 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $155,688 - $483,574	5,792 Added 2.22%	266,771 $22.3 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $30.7 Million - $38.4 Million	-942,276 Reduced 78.31%	260,979 $8.51 Million
Q1 2023 May 12, 2023	BUY	$33.36 - $45.71 $28.5 Million - $39 Million	854,101 Added 244.62%	1,203,255 $42.3 Million
Q4 2022 Feb 10, 2023	BUY	$35.77 - $51.11 $3.05 Million - $4.36 Million	85,215 Added 32.29%	349,154 $16 Million

Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.25 Million - $1.77 Million	32,463 Added 14.02%	263,939 $12.8 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $6.37 Million - $9.18 Million	-187,681 Reduced 44.78%	231,476 $9.09 Million
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $3.7 Million - $5.72 Million	124,424 Added 42.22%	419,157 $15.4 Million
Q4 2021 Feb 08, 2022	BUY	$34.35 - $46.38 $2.17 Million - $2.93 Million	63,094 Added 27.24%	294,733 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $255,166 - $491,889	-13,763 Reduced 5.61%	231,639 $8.28 Million
Q2 2021 Sep 13, 2021	BUY	$19.79 - $26.99 $4.86 Million - $6.62 Million	245,402 New	245,402 $4.86 Million

Others Institutions Holding CYTK

# of Institutions

459

Shares Held

108M

Call Options Held

7.2M

Put Options Held

6.2M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.98B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cytokinetics Inc Transaction History